Paclitaxel nanosuspension coated with P-gp inhibitory surfactants: II. Ability to reverse the drug-resistance of H460 human lung cancer cells
Lei Gao(First Affiliated Hospital of Chinese PLA General Hospital), Junzhong Sun(First Affiliated Hospital of Chinese PLA General Hospital), Xiaoqing Wang(Roche (China)), Hongwei Wang(Albert Einstein College of Medicine), Guiyang Liu(Soochow University), Fang Wang(First Affiliated Hospital of Chinese PLA General Hospital), Jianli Ma(First Affiliated Hospital of Chinese PLA General Hospital)
Cited by 37
Related Papers
Integrative analysis of pooled CRISPR genetic screens using MAGeCKFlute
|Nature Protocols|2019|485
Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade
|Cancer Discovery|2021|286
Single-cell and spatial transcriptome analysis reveals the cellular heterogeneity of liver metastatic colorectal cancer
|Science Advances|2023|220
In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target
|Cell|2021|200
Evaluation of lipid accumulation from lignocellulosic sugars by Mortierella isabellina for biodiesel production
|Bioresource Technology|2012|155